Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
BMC Medicine
Published in: BMC Medicine 1/2014

Open Access 01-12-2014 | Research article

Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study

Authors: Shaheen Pandie, Jonathan G Peter, Zita S Kerbelker, Richard Meldau, Grant Theron, Ureshnie Govender, Mpiko Ntsekhe, Keertan Dheda, Bongani M Mayosi

Published in: BMC Medicine | Issue 1/2014

Login to get access

Abstract

Background

Tuberculous pericarditis (TBP) is associated with high morbidity and mortality, and is an important treatable cause of heart failure in developing countries. Tuberculous aetiology of pericarditis is difficult to diagnose promptly. The utility of the new quantitative PCR test (Xpert MTB/RIF) for the diagnosis of TBP is unknown. This study sought to evaluate the diagnostic accuracy of the Xpert MTB/RIF test compared to pericardial adenosine deaminase (ADA) and unstimulated interferon-gamma (uIFNγ) in suspected TBP.

Methods

From October 2009 through September 2012, 151 consecutive patients with suspected TBP were enrolled at a single centre in Cape Town, South Africa. Mycobacterium tuberculosis culture and/or pericardial histology served as the reference standard for definite TBP. Receiver-operating-characteristic curve analysis was used for selection of ADA and uIFNγ cut-points.

Results

Of the participants, 49% (74/151) were classified as definite TBP, 33% (50/151) as probable TBP and 18% (27/151) as non TBP. A total of 105 (74%) participants were human immunodeficiency virus (HIV) positive. Xpert-MTB/RIF had a sensitivity and specificity (95% confidence interval (CI)) of 63.8% (52.4% to 75.1%) and 100% (85.6% to 100%), respectively. Concentration of pericardial fluid by centrifugation and using standard sample processing did not improve Xpert MTB/RIF accuracy. ADA (≥35 IU/L) and uIFNγ (≥44 pg/ml) both had a sensitivity of 95.7% (88.1% to 98.5%) and a negative likelihood ratio of 0.05 (0.02 to 0.10). However, the specificity and positive likelihood ratio of uIFNγ was higher than ADA (96.3% (81.7% to 99.3%) and 25.8 (3.6 to 183.4) versus 84% (65.4% to 93.6%) and 6.0 (3.7 to 9.8); P = 0.03) at an estimated background prevalence of TB of 30%. The sensitivity and negative predictive value of both uIFNγ and ADA were higher than Xpert-MT/RIF (P < 0.001).

Conclusions

uIFNγ offers superior accuracy for the diagnosis of microbiologically confirmed TBP compared to the ADA assay and the Xpert MTB/RIF test.
Appendix
Available only for authorised users
Literature
1.
World Health Organization: Global Tuberculosis Report 2013. 2013, Geneva
2.
3.
Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parrish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Magula NP, Commerford PJ: Mortality in patients treated for tuberculous pericarditis in sub-Saharan Africa. S Afr Med J. 2008, 98: 36-40.PubMed
4.
Damasceno A, Mayosi BM, Sani M, Ogah OS, Mondo C, Dike O, Dzudie A, Kouam Kouam C, Suliman A, Schrueder N, Yonga G, Ba SA, Maru F, Alemayehu B, Edwards C, Davison BA, Cotter G, Sliwa K: The causes, treatment, and outcome of acute heart failure in 1006 Africans from 9 countries: results of the sub-saharan africa survey of heart failure. Arch Int Med. 2012, 172: 1386-1394.CrossRef
5.
6.
Reuter H, Burgess L, van Vuuren W, Doubell A: Diagnosing tuberculous pericarditis. QJM. 2006, 99: 827-839.CrossRefPubMed
7.
Strang G, Latouf S, Commerford P, Roditi D, Duncan-Traill G, Barlow D, Forder A: Bedside culture to confirm tuberculous pericarditis. Lancet. 1991, 338: 1600-1601.CrossRefPubMed
8.
Holtz TH, Kabera G, Mthiyane T, Zingoni T, Nadesan S, Ross D, Allen J, Chideya S, Sunpath H, Rustomjee R: Use of a WHO-recommended algorithm to reduce mortality in seriously ill patients with HIV infection and smear-negative pulmonary tuberculosis in South Africa: an observational cohort study. Lancet Infect Dis. 2011, 11: 533-540.CrossRefPubMed
9.
Boehme CC, Nabeta P, Hillemann D, Nicol MP, Shenai S, Krapp F, Allen J, Tahirli R, Blakemore R, Rustomjee R, Milovic A, Jones M, O'Brien SM, Persing DH, Ruesch-Gerdes S, Gotuzzo E, Rodrigues C, Alland D, Perkins MD: Rapid molecular detection of tuberculosis and rifampin resistance. N Engl J Med. 2010, 363: 1005-1015.CrossRefPubMedPubMedCentral
10.
11.
Steingart KR, Sohn H, Schiller I, Kloda LA, Boehme CC, Pai M, Dendukuri N: Xpert(R) MTB/RIF assay for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev. 2013, 1: CD009593
12.
Dhana AV, Howell P, Sanne I, Spencer D: Identification of Mycobacterium tuberculosis from pericardial fluid using the new Xpert MTB/RIF assay. BMJ Case Rep. 2013, doi:10.1136/bcr-2013-200615
13.
Vadwai V, Boehme C, Nabeta P, Shetty A, Alland D, Rodrigues C: Xpert MTB/RIF: a new pillar in diagnosis of extrapulmonary tuberculosis?. J Clin Microbiol. 2011, 49: 2540-2545.CrossRefPubMedPubMedCentral
14.
Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF: The use of adenosine deaminase and interferon-{gamma} as diagnostic tools for tuberculous pericarditis. Chest. 2002, 122: 900-905.CrossRefPubMed
15.
Dheda K, van Zyl-Smit RN, Sechi LA, Badri M, Meldau R, Meldau S, Symons G, Semple PL, Maredza A, Dawson R, Wainwright H, Whitelaw A, Vallie Y, Raubenheimer P, Bateman ED, Zumla A: Utility of quantitative T-cell responses versus unstimulated interferon-{gamma} for the diagnosis of pleural tuberculosis. Eur Respir J. 2009, 34: 1118-1126.CrossRefPubMed
16.
Reuter H, Burgess LJ, Carstens ME, Doubell AF: Adenosine deaminase activity–more than a diagnostic tool in tuberculous pericarditis. Cardiovasc J S Afr. 2005, 16: 143-147.PubMed
17.
Mayosi BM, Wiysonge CS, Ntsekhe M, Volmink JA, Gumedze F, Maartens G, Aje A, Thomas BM, Thomas KM, Awotedu AA, Thembela B, Mntla P, Maritz F, Blackett KN, Nkouonlack DC, Burch VC, Rebe K, Parish A, Sliwa K, Vezi BZ, Alam N, Brown BG, Gould T, Visser T, Shey MS, Magula NP, Commerford PJ: Clinical characteristics and initial management of patients with tuberculous pericarditis in the HIV era: the Investigation of the Management of Pericarditis in Africa (IMPI Africa) registry. BMC Infect Dis. 2006, 6: 2.CrossRefPubMedPubMedCentral
18.
19.
White IR, Royston P, Wood AM: Multiple imputation using chained equations: issues and guidance for practice. Stat Med. 2011, 30: 377-399.CrossRefPubMed
20.
Schisterman EF, Perkins NJ, Liu A, Bondell H: Optimal cut-point and its corresponding Youden Index to discriminate individuals using pooled blood samples. Epidemiology. 2005, 16: 73-81.CrossRefPubMed
21.
Bossuyt PM, Reitsma JB, Bruns DE, Gatsonis CA, Glasziou PP, Irwig LM, Moher D, Rennie D, de Vet HC, Lijmer JG: The STARD statement for reporting studies of diagnostic accuracy: explanation and elaboration. Ann Intern Med. 2003, 138: W1-W12.CrossRefPubMed
22.
Burgess LJ, Reuter H, Carstens ME, Taljaard JJ, Doubell AF: The use of adenosine deaminase and interferon-gamma as diagnostic tools for tuberculous pericarditis. Chest. 2002, 122: 900-905.CrossRefPubMed
23.
Ligthelm LJ, Nicol MP, Hoek KG, Jacobson R, van Helden PD, Marais BJ, Warren RM, Wright CA: Xpert MTB/RIF for rapid diagnosis of tuberculous lymphadenitis from fine-needle-aspiration biopsy specimens. J Clin Microbiol. 2011, 49: 3967-3970.CrossRefPubMedPubMedCentral
24.
Meldau R, Peter J, Theron G, Calligaro G, Allwood B, Symons G, Khalfey H, Ntombenhle G, Govender U, Binder A, van Zyl-Smit R, Dheda K: Comparison of same day diagnostic tools including Gene Xpert and unstimulated IFN-gamma for the evaluation of pleural tuberculosis: a prospective cohort study. BMC Pulm Med. 2014, 14: 58.CrossRefPubMedPubMedCentral
25.
Patel VB, Theron G, Lenders L, Matinyena B, Connolly C, Singh R, Coovadia Y, Ndung’u T, Dheda K: Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous meningitis in a high burden setting: a prospective study. PLoS Med. 2013, 10: e1001536.CrossRefPubMedPubMedCentral
26.
Lawn SD, Mwaba P, Bates M, Piatek A, Alexander H, Marais BJ, Cuevas LE, McHugh TD, Zijenah L, Kapata N, Abubakar I, McNerney R, Hoelscher M, Memish ZA, Migliori GB, Kim P, Maeurer M, Schito M, Zumla A: Advances in tuberculosis diagnostics: the Xpert MTB/RIF assay and future prospects for a point-of-care test. Lancet Infect Dis. 2013, 13: 349-361.CrossRefPubMedPubMedCentral
27.
Mayosi BM, Lawn JE, van Niekerk A, Bradshaw D, Abdool Karim SS, Coovadia HM: Health in South Africa: changes and challenges since 2009. Lancet. 2012, 380: 2029-2043.CrossRefPubMed
28.
Peter JG, Theron G, Muchinga TE, Govender U, Dheda K: The diagnostic accuracy of urine-based Xpert MTB/RIF in HIV-infected hospitalized patients who are smear-negative or sputum scarce. PLoS One. 2012, 7: e39966.CrossRefPubMedPubMedCentral
29.
Peter JG, Theron G, Pooran A, Thomas J, Pascoe M, Dheda K: Comparison of two methods for acquisition of sputum samples for diagnosis of suspected tuberculosis in smear-negative or sputum-scarce people: a randomised controlled trial. Lancet Respir Med. 2013, 1: 471-478.CrossRefPubMedPubMedCentral
30.
Helb D, Jones M, Story E, Boehme C, Wallace E, Ho K, Kop J, Owens MR, Rodgers R, Banada P, Safi H, Blakemore R, Lan NT, Jones-López EC, Levi M, Burday M, Ayakaka I, Mugerwa RD, McMillan B, Winn-Deen E, Christel L, Dailey P, Perkins MD, Persing DH, Alland D: Rapid detection of Mycobacterium tuberculosis and rifampin resistance by use of on-demand, near-patient technology. J Clin Microbiol. 2010, 48: 229-237.CrossRefPubMed
31.
Hillemann D, Rusch-Gerdes S, Boehme C, Richter E: Rapid molecular detection of extrapulmonary tuberculosis by the automated GeneXpert MTB/RIF system. J Clin Microbiol. 2011, 49: 1202-1205.CrossRefPubMedPubMedCentral
32.
Banada PP, Koshy R, Alland D: Detection of Mycobacterium tuberculosis in blood by use of the Xpert MTB/RIF assay. J Clin Microbiol. 2013, 51: 2317-2322.CrossRefPubMedPubMedCentral
33.
Theron G, Peter J, van Zyl-Smit R, Mishra H, Streicher E, Murray S, Dawson R, Whitelaw A, Hoelscher M, Sharma S, Pai M, Warren R, Dheda K: Evaluation of the Xpert MTB/RIF assay for the diagnosis of pulmonary tuberculosis in a high HIV prevalence setting. Am J Respir Crit Care Med. 2011, 184: 132-140.CrossRefPubMed
34.
Latouf SE, Ress SR, Lukey PT, Commerford PJ: Interferon-gamma in pericardial aspirates: a new, sensitive and specific test for the diagnosis of tuberculous pericarditis. Circulation. 1991, 84: II-149. [Abstract]
35.
Sharma SK, Banga A: Pleural fluid interferon-gamma and adenosine deaminase levels in tuberculosis pleural effusion: a cost-effectiveness analysis. J Clin Lab Anal. 2005, 19: 40-46.CrossRefPubMed
Metadata
Title
Diagnostic accuracy of quantitative PCR (Xpert MTB/RIF) for tuberculous pericarditis compared to adenosine deaminase and unstimulated interferon-γ in a high burden setting: a prospective study
Authors
Shaheen Pandie
Jonathan G Peter
Zita S Kerbelker
Richard Meldau
Grant Theron
Ureshnie Govender
Mpiko Ntsekhe
Keertan Dheda
Bongani M Mayosi
Publication date
01-12-2014
Publisher
BioMed Central
Published in
BMC Medicine / Issue 1/2014
Electronic ISSN: 1741-7015
DOI
https://doi.org/10.1186/1741-7015-12-101

Other articles of this Issue 1/2014

BMC Medicine 1/2014 Go to the issue

Research article

The association between the ratio of monocytes:lymphocytes at age 3 months and risk of tuberculosis (TB) in the first two years of life

Question and Answer

Video Q & A: The impact of stress. An interview with George Chrousos

Research article

How much is tuberculosis screening worth? Estimating the value of active case finding for tuberculosis in South Africa, China, and India

Research article

Can authorities appreciably enhance the prescribing of oral generic risperidone to conserve resources? Findings from across Europe and their implications

Research article

Validity of self-measured waist circumference in adults at risk of type 2 diabetes and cardiovascular disease

Research article

The epidemiology of silent brain infarction: a systematic review of population-based cohorts